NK/DC crosstalk in anti-viral response

Advances in Experimental Medicine and Biology

Volumn 946, Issue , 2012, Pages 295-308

  Marcenaro, Emanuela ^b   Carlomagno, Simona ^b   Pesce, Silvia ^b   Moretta, Alessandro ^a   Sivori, Simona ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b NONE

Author keywords

Activating receptors; Cytokines; Dendritic cells; Natural killer cells; Viral infection

Indexed keywords

CYTOKINE; NATURAL KILLER CELL RECEPTOR; VIRUS ANTIGEN;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; ARTICLE; CELL CONTACT; CELL MATURATION; CYTOLYSIS; CYTOMEGALOVIRUS INFECTION; DENDRITIC CELL; HUMAN; IMMUNE RESPONSE; INFLUENZA; LYMPHOCYTE SUBPOPULATION; LYMPHOID TISSUE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTION;

ANIMALS; CELL COMMUNICATION; DENDRITIC CELLS; HUMANS; KILLER CELLS, NATURAL; RECEPTOR CROSS-TALK; VIRUS DISEASES;

EID: 80555133240     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-0106-3_17     Document Type: Article

References (90)

1. Agaugué S., Marcenaro E., Ferranti B., Moretta L. and Moretta A.2008) Human natural killer cells exposed to IL-2, IL-12, IL-18, or IL-4 differently modulate priming of naive T cells by monocyte-derived dendritic cells. Blood 112, 1776-1783
2. Andoniou C.E., van Dommelen S.L., Voigt V., Andrews D.M., Brizard G., Asselin-Paturel C., Delale T., Stacey K.J., Trinchieri G. and Degli-Esposti M.A.2005) Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity. Nat. Immunol. 6, 1011-1019
3. Andrews D.M., Scalzo A.A., Yokoyama W.M., Smyth M.J. and Degli-Esposti M.A.2003) Functional interactions between dendritic cells and NK cells during viral infection. Nat. Immunol. 4, 175-181
4. Anfossi N., Andre P., Guia S., Falk C.S., Roetynck S., Stewart C.A., Breso V., Frassati C., Reviron D., Middleton D., Romagné F., Ugolini S. and Vivier E.2006) Human NK cell education by inhibitory receptors for MHC class I. Immunity 25, 331-342
5. Arase H., Mocarski E.S., Campbell A.E., Hill A.B. and Lanier L.L.2002) Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296, 1323-1326
6. Arnon T.I,. Achdout H., Lieberman N., Gazit R., Gonen-Gross T., Katz G., Bar-Ilan A., Bloushtain N., Lev M., Joseph A., Kedar E., Porgador A. and Mandelboim O.2004) The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46. Blood 103, 664-672
7. Banchereau J. and Steinman R.M.1998) Dendritic cells and the control of immunity. Nature 392, 245-52
8. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu J.Y., Pulendran B. and Palucka K.2000) Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 767-811
9. Bancroft G.J., Shellam G.R. and Chalmer J.E.1981) Genetic influences on the augmentation of natural killer (NK) cells during murine cytomegalovirus infection: correlation with patterns of resistance. J. Immunol. 126, 988-994
10. Barr D.P., Belz G.T., Reading P.C., Wojtasiak M., Whitney P.G., Heath W.R., Carbone F.R. and Brooks A.G.2007) A role for plasmacytoid dendritic cells in the rapid IL-18-dependent activation of NK cells following HSV-1 infection. Eur. J. Immunol. 37, 1334-1342
11. Belz G., Mount A. and Masson F.2009) Dendritic cells in viral infections. Handb. Exp. Pharmacol. 188, 51-77
12. Biassoni R., Cantoni C., Falco M., Verdiani S., Bottino C., Vitale M., Conte R., Poggi A., Moretta A. and Moretta L.1996) The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J. Exp. Med. 183, 645-650
13. Biron C.A.1999) Initial and innate responses to viral infections - pattern setting in immunity or disease. Curr. Opin. Microbiol. 2, 374-381
14. Bottino C., Castriconi R., Moretta L. and Moretta A.2005) Cellular ligands of activating NK receptors. Trends Immunol. 26, 221-226
15. Bottino C., Falco M., Parolini S., Marcenaro E., Augugliaro R., Sivori S., Landi E., Biassoni R., Notarangelo L.D., Moretta L. and Moretta A.2001) NTB-A, a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virusinfected B cells in X-linked lymphoproliferative disease. J. Exp. Med. 194, 235-246
16. Brandt C.S., Baratin M., Yi E.C., Kennedy J., Gao Z., Fox B., Haldeman B., Ostrander C.D., Kaifu T., Chabannon C., Moretta A., West R., Xu W., Vivier E. and Levin S.D.2009) The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans. J. Exp. Med. 206, 1495-1503
17. Braud V.M., Allan D.S., O'Callaghan C.A., Söderström K., D'Andrea A., Ogg G.S., Lazetic S., Young N.T., Bell J.I., Phillips J.H., Lanier L.L. and McMichael A.J.1998) HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391, 795-799
18. Brown M.H., Boles K., van der Merwe P.A., Kumar V., Mathew P.A. and Barclay A.N.1998) 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48. J. Exp. Med. 188, 2083-2090
19. Chewning J.H., Gudme C.N., Hsu K.C., Selvakumar A. and Dupont B.2007) KIR2DS1-positive NK cells mediate alloresponse against the C2 HLA-KIR ligand group in vitro. J. Immunol. 179, 854-868
20. Cooper M.A., Fehniger T.A. and Caligiuri M.A.2001) The biology of human natural killer cell subsets. Trends Immunol. 22, 633-640
21. Cooper M.A., Fehniger T.A., Fuchs A., Colonna M., and Caligiuri M.A.2004) NK cell and DC interactions. Trends Immunol. 25, 47-52
22. Degli-Esposti M.A. and Smyth M.J.2005) Close encounters of different kinds: dendritic cells and NK cells take centre stage. Nat. Rev. Immunol. 5, 112-124
23. Della Chiesa M., Romagnani C., Thiel A., Moretta L. and Moretta A.2006) Multidirectional interactions are bridging human NK cells with plasmacytoid and monocyte-derived dendritic cells during innate immune responses. Blood 108, 3851-3858
24. Della Chiesa M., Sivori S., Castriconi R., Marcenaro E. and Moretta A.2005) Pathogen-induced private conversations between natural killer and dendritic cells. Trends Microbiol. 13, 128-136
25. Della Chiesa M., Vitale M., Carlomagno S., Ferlazzo G., Moretta L. and Moretta A.2003) The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. Eur. J. Immunol. 33, 1657-1666
26. Diefenbach A. and Raulet D.H.2001) Strategies for target cell recognition by natural killer cells. Immunol. Rev. 181, 170-184
27. Draghi M., Pashine A., Sanjanwala B., Gendzekhadze K., Cantoni C., Cosman D., Moretta A., Valiante N.M. and Parham P.2007) NKp46 and NKG2D Recognition of Infected Dendritic Cells Is Necessary for NK Cell Activation in the Human Response to Influenza Infection. J. Immunol. 178(5), 2688-2698
28. Dunn C., Chalupny N.J., Sutherland C.L., Dosch S., Sivakumar P.V., Johnson D.C. and Cosman D.2003) Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity. J. Exp. Med. 197, 1427-1439
29. Falco M., Marcenaro E., Romeo E., Bellora F., Marras D., Vély F., Ferracci G., Moretta L., Moretta A. and Bottino C.2004) Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells. Eur. J. Immunol. 34, 1663-1672
30. Ferlazzo G. and Munz C.2004) NK cell compartments and their activation by dendritic cells. J. Immunol. 172, 1333-1339
31. Ferlazzo G., Pack M., Thomas D., Paludan C., Schmid D., Strowig T., Bougras G., Muller W.A., Moretta L. and Munz C.2004a) Distinct roles of IL12 and IL15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc. Natl. Acad. Sci. USA 101, 16606-16611
32. Ferlazzo G., Thomas D., Lin S.L., Goodman K., Morandi B., Muler W.A., Moretta A. and Munz C.2004b) The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J. Immunol. 172, 1455-1462
33. Ferlazzo G., Tsang M.L., Moretta L., Melioli G., Steinman R.M. and Munz C.2002) Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J. Exp. Med. 195, 343-351
34. Freud A.G. and Caligiuri M.A.2006) Human natural killer cell development. Immunol. Rev. 214, 56-72
35. Gazit R., Gruda R., Elboim M., Arnon T.I., Katz G., Achdout H., Hanna J., Qimron U., Landau G., Greenbaum E., Zakay-Rones Z., Porgador A. and Mandelboim O.2006) Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat. Immunol. 7, 517-523
36. Gerosa F., Baldani-Guerra B., Nisii C., Marchesini V., Carra G. and Trinchieri G.2002) Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med. 195, 327-333
37. Graef T., Moesta A.K., Norman P.J., Abi-Rached L., Vago L., Older Aguilar A.M., Gleimer M., Hammond J.A., Guethlein L.A., Bushnell D.A., Robinson P.J. and Parham P.2009) KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A. *11 while diminishing avidity for HLA-C. J. Exp. Med. 206, 2557-2572
38. Granucci F., Zanoni I., Pavelka N., Van Dommelen S.L., Andoniou C.E., Belardelli F., Degli Esposti M.A. and Ricciardi-Castagnoli P.2004) A contribution of mouse dendritic cell-derived IL-2 for NK cell activation. J. Exp. Med. 200, 287-295
39. He X.S., Draghi M., Mahmood K., Holmes T.H., Kemble G.W., Dekker C.L., Arvin A.M., Parham P. and Greenberg H.B.2004) T cell-dependent production of IFN-gamma by NK cells in response to influenza A virus. J. Clin. Investig. 114, 1812-1819
40. Heltzer M.L., Coffin S.E., Maurer K., Bagashev A., Zhang Z., Orange J.S. and Sullivan K.E.2009) Immune dysregulation in severe influenza. J. Leukoc. Biol. 85, 1036-1043
41. Jonjic S., Babic M., Polic B. and Krmpotic A.2008b) Immune evasion of natural killer cells by viruses. Curr. Opin. Immunol. 20, 30-38
42. Jonjic S., Polic B. and Krmpotic A.2008a) Viral inhibitors of NKG2D ligands: friends or foes of immune surveillance? Eur. J. Immunol. 38, 2952-2956
43. Kärre K.2008) Natural killer cell recognition of missing self. Nat. Immunol. 9, 477-480
44. Lodoen M.B. and Lanier L.L.2005) Viral modulation of NK cell immunity. Nat. Rev. Microbiol. 3, 59-69
45. Magri G., Muntasell A., Romo N., Saez-Borderías A., Pende D., Geraghty D.E., Hengel H., Angulo A., Moretta A. and López-Botet M.2011) NKp46 and DNAM-1 NK cell receptors drive the response to human cytomegalovirus infected myeloid dendritic cells overcoming viral immune evasion strategies. Blood 117, 848-856
46. Mailliard R.B., Alber S.M., Shen H. Watkins S.C., Kirkwood J.M., Herberman R.B. and Kalinski P.2005) IL-18-induced CD83+CCR7+ NK helper cells. J. Exp. Med. 202, 941-953
47. Mandelboim O., Lieberman N., Lev M., Paul L., Arnon T.I., Bushkin Y., Davis D.M., Strominger J.L., Yewdell J.W. and Porgador A.2001) Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409, 1055-1060
48. Mao H., Tu W., Liu Y., Qin G., Zheng J., Chan P.L., Lam K.T., Peiris M. and Lau Y.L.2010) Inhibition of human natural killer cell activity by influenza virions and hemagglutinin. J. Virol. 84, 4148-4157
49. Mao H., Tu W., Qin G., Law H.K., Sia S.F., Chan P.L., Liu Y., Lam K.T., Zheng J., Peiris M. and Lau Y.L.2009) Influenza virus directly infects human natural killer cells and induces cell apoptosis. J. Virol. 83, 9215-9222
50. Marcenaro E., Cantoni C., Pesce S., Prato C., Pende D., Agaugué S., Moretta L. and Moretta A.2009) Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines: regulation by KIR/HLA-class I interaction. Blood 114, 4108-4116
51. Marcenaro E., Ferranti B., Falco M., Moretta L. and Moretta A.2008) Human NK cells directly recognize Mycobacterium bovis via TLR2 and acquire the ability to kill monocyte-derived DC. Int. Immunol. 20, 1155-1167
52. Marcenaro E., Ferranti B. and Moretta A.2005a) NK-DC interaction: on the usefulness of autoaggression. Autoimmun. Rev. 4, 520-525
53. Marcenaro E., Della Chiesa M., Bellora F., Parolini S., Millo R., Moretta L. and Moretta A.2005b) IL12 or IL4 prime human Natural Killer cells to mediate functionally divergent interactions with dendritic cells or tumors. J. Immunol. 174, 3992-3998
54. Martin-Fontecha A., Thomsen L.L., Brett S., Gerard C., Lipp M., Lanzavecchia A. and Sallusto F.2004) Induced recruitment of NK cells to lymph nodes provides IFN-gamma for Th1 priming. Nat. Immunol. 5, 1260-1265
55. Moretta A.2002) Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat. Rev. Immunol. 2, 957-964
56. Moretta L., Biassoni R., Bottino C., Cantoni C., Pende D., Mingari M.C. and Moretta A.2000) Human NK-cell receptors. Immunol. Today 21, 420-422
57. Moretta A., Bottino C., Vitale M., Pende D., Biassoni R., Mingari M.C. and Moretta L.1996) Receptors for HLA class-I molecules in human natural killer cells. Annu. Rev. Immunol. 14, 619-648
58. Moretta A., Bottino C., Vitale M., Pende D., Cantoni C., Mingari M. C., Biassoni R. and Moretta L.2001) Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 19, 197-223
59. Moretta A., Marcenaro E., Parolini S., Ferlazzo G. and Moretta L.2008) NK cells at the interface between innate and adaptive immunity. Cell Death Differ. 15(2), 226-233
60. Moretta A., Marcenaro E., Sivori S., Chiesa M.D., Vitale M. and Moretta L.2005) Early liaisons between cells of the innate immune system in inflamed peripheral tissues. Trends Immunol. 26, 668-675
61. Moretta A., Sivori S., Vitale M., Pende D., Morelli L., Augugliaro R., Bottino C. and Moretta L.1995) Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J. Exp. Med. 182, 875-884
62. Orange J.S. and Biron C.A.1996) Characterization of early IL-12, IFN-alphabeta, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. J. Immunol. 156, 4746-4756
63. Parolini S., Santoro A., Marcenaro E., Luini W, Massardi L., Facchetti F., Communi D., Parmentier M., Majorana A., Sironi M., Tabellini G., Moretta A. and Sozzani S.2007) The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood 109, 3625-3632
64. Pende D., Parolini S., Pessino A., Sivori S., Augugliaro R., Morelli L., Marcenaro E., Accame L., Malaspina A., Biassoni R., Bottino C., Moretta L. and Moretta A.1999) Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J. Exp. Med. 190, 1505-1516
65. Perussia B., Starr S., Abraham S., Fanning V. and Trinchieri G.1983) Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1. J. Immunol. 130, 2133-2141
66. Pessino A., Sivori S., Bottino C., Malaspina A., Morelli L., Moretta L., Biassoni R. and Moretta A.1998) Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. J. Exp. Med. 188, 953-960
67. Piccioli D., Sbrana S., Melandri E. and Valiante N.M.2002) Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J. Exp. Med. 195, 335-341
68. Raulet D.H.2003) Roles of the NKG2D immunoreceptor and its ligands. Nat. Rev. Immunol. 3, 781-790
69. Reymond N., Imbert A.M., Devilard E., Fabre S., Chabannon C., Xerri L., Farnarier C., Cantoni C., Bottino C., Moretta A., Dubreuil P. and Lopez M.2004) DNAM-1 and PVR regulate monocyte migration through endothelial junctions. J. Exp. Med. 199, 1331-1341
70. Romagnani C., Juelke K., D'Agostino A., Costa R., Ratto G., Forte G., Carrega P., Morandi B., Lui G., Munz C., Moretta A., Thiel A., Moretta L. and Ferlazzo G.2007) CD56 bright CD16- Killer Ig-like receptors (KIR)- NK cells progress into CD56 dimCD16+KIR+ NK cells upon activation. J. Immunol. 178, 4947-4955
71. Sivori S., Falco M., Carlomagno S., Romeo E., Soldani C., Bensussan A., Viola A., Moretta L. and Moretta A.2010a) A novel KIR- associated function: evidence that CpG DNA uptake and shuttling to early endosomes is mediated by KIR3DL2. Blood 116, 1637-1647
72. Sivori S., Falco M., Della Chiesa M., Carlomagno S., Vitale M., Moretta L. and Moretta A.2004) CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc. Natl. Acad. Sci. U S A 101, 10116-10121
73. Sivori S., Falco M., Moretta L. and Moretta A.2010b) Extending Killer Ig-like receptor function: from HLA-class I recognition to sensors of microbial products. Trends Immunol. 31, 289-294
74. Sivori S., Parolini S., Falco M., Marcenaro E., Biassoni R., Bottino C., Moretta L. and Moretta A.2000) 2B4 functions as a co-receptor in human NK cell activation. Eur. J. Immunol. 30, 787-793
75. Sivori S., Pende D., Bottino C., Marcenaro E., Pessino A., Biassoni R., Moretta L. and Moretta A.1999) NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells. Eur. J. Immunol. 29, 1656-1666
76. Sivori S., Vitale M., Morelli L., Sanseverino L., Augugliaro R., Bottino C., Moretta L. and Moretta A.1997) p46, a novel natural killer cell-specific surface molecule that mediates cell activation. J. Exp. Med. 186, 1129-1136
77. Smith H.R., Heusel J.W., Mehta I.K., Kim S., Dorner B.G., Naidenko O.V., Iizuka K., Furukawa H., Beckman D.L., Pingel J.T., Scalzo A.A., Fremont D.H. and Yokoyama W.M.2002) Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc. Natl. Acad. Sci. USA 99, 8826-8831
78. Spies T. and Groh V.2006) Natural cytotoxicity receptors: influenza virus in the spotlight. Nat. Immunol. 7, 443-444
79. Stewart C.A., Laugier-Anfossi F., Vély F., Saulquin X., Riedmuller J., Tisserant A., Gauthier L., Romagné F., Ferracci G., Arosa F.A., Moretta A., Sun P.D., Ugolini S. and Vivier E.2005) Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. Proc. Natl. Acad. Sci. U S A 102, 13224-13229
80. Sutherland C.L., Chalupny N.J. and Cosman D.2001) The UL16-binding proteins, a novel family of MHC class I-related ligands for NKG2D, activate natural killer cell functions. Immunol. Rev. 181, 185-192
81. Trinchieri G.1989) Biology of natural killer cells. Adv. Immunol. 47, 187-376
82. Vitale M., Bottino C., Sivori S., Sanseverino L., Castriconi R., Marcenaro E., Augugliaro R., Moretta L. and Moretta A.1998) NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complexrestricted tumor cell lysis. J. Exp. Med. 187, 2065-2072
83. Vitale M., Della Chiesa M., Carlomagno S., Pende D., Arico M., Moretta L. and Moretta A. (2005) NK-dependent DC maturation is mediated by TNF-a and IFN-gamma released upon engagement of the NKp30 triggering receptor. Blood 106, 566-571
84. Vitale M., Della Chiesa M., Carlomagno S., Romagnani C., Thiel A., Moretta L. and Moretta A.2004) The small subset of CD56brightCD16- natural killer cells is selectively responsible for both cell proliferation and interferon-gamma production upon interaction with dendritic cells. Eur. J. Immunol. 34, 1715-1722
85. Vitale M., Falco M., Castriconi R., Parolini S., Zambello R., Semenzato G., Biassoni R., Bottino C., Moretta L. and Moretta A.2001) Identification of NKp80, a novel triggering molecule expressed by human NK cells. Eur. J. Immunol. 31, 233-242
86. Walzer T., Dalod M., Vivier E. and Zitvogel L.2005) Natural-killer cells and dendritic cells: "l'union fait la force". Blood 106, 2252-2258
87. Welliver T.P., Garofalo R.P., Hosakote Y., Hintz K.H., Avendano L., Sanchez K., Velozo L., Jafri H., Chavez-Bueno S., Ogra P. L., McKinney L., Reed J.L., and Welliver R.C. Sr.2007) Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J. Infect. Dis. 195, 1126-1136
88. Welte S., Kuttruff S., Waldhauer I. and Steinle A.2006) Mutual activation of natural killer cells and monocytes mediated by NKp80-AICL interaction. Nat. Immunol. 7, 1334-1342
89. Wu J., Chalupny N.J., Manley T.J., Riddell S.R., Cosman D. and Spies T.2003) Intracellular retention of the MHC class I-related chain B ligand of NKG2D by the human cytomegalovirus UL16 glycoprotein. J. Immunol. 170, 4196-4200
90. Zitvogel L.2002) Dendritic and natural killer cells cooperate in the control/ switch of innate immunity. J. Exp. Med. 195, F9-F14